ICMR, India’s apex Health Research Facility, isolates COVID-19

New Delhi: Indian Council of Medical Research (ICMR), the apex health research body of India has successfully isolated the COVID-19 virus strain. The isolation is the first step towards expediting the development of drugs, vaccines and rapid diagnostic kits in the country.

The other countries that have isolated the virus are Japan, Thailand, United States of America and China. ICMR has been closely working with the Ministry of Health, and other departments to coordinate the effort to tackle COVID-19.

ICMR, which is also the testing agency for the virus, has expanded its network of labs equipped to test COVID-19 from 51 to 65. The secondary test for reconfirmation of the virus which was earlier conducted only in National Institute of Virology have also been expanded to 31 labs. These steps will enable India to expedite detection of the virus and will help in effective management.

Till date ICMR has tested more than 6500 samples of 5900 individuals, out of which 78 cases have been tested positive for the virus. ICMR is equipped to handle more volumes of samples if the need arises.

Prof (Dr) Balram Bhargava, Secretary, Department of Health Research & Director General, ICMR, said “People should not panic, but take precautionary measures. Strong systems and processes are in place to deal with COVID-19 and the Ministry is constantly monitoring the situation. We at ICMR have been constantly in a vigil mode and our laboratories have enough capacity to test. We will be issuing advisories and revising guidelines for testing as and when necessary.”

Related Posts

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

IPC releases draft NFI-2026 to promote rational use of medicines

Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’